Behavioural characterisation of the effects of acute and repeated administration of GBR 12909 in rats: Further evaluation of a potential model of ADHD

Neuropharmacology

Volumn 57, Issue 7-8, 2009, Pages 678-686

  Hewitt, Katherine N ^a   Marsden, Charles A ^a   Hollis, Chris P ^b   Fone, Kevin C F ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Behavioural Sciences Section   (United Kingdom)

Author keywords

ADHD; Behaviour; Dopamine transporter; GBR 12909; Rat

Indexed keywords

DOPAMINE TRANSPORTER; VANOXERINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CONTROLLED STUDY; DRUG WITHDRAWAL; LEARNING DISORDER; LOCOMOTION; MEMORY DISORDER; MENTAL TASK; NEUROBIOLOGY; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; STARTLE REFLEX; UPREGULATION;

ACOUSTIC STIMULATION; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; EXPLORATORY BEHAVIOR; MALE; MOTOR ACTIVITY; PIPERAZINES; RATS; STARTLE REACTION;

EID: 70350397056     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.08.006     Document Type: Article

References (51)

1. Adams J.U., Efferen T.R., Duncan E.J., and Rotrosen J. Prepulse inhibition of the acoustic startle response in cocaine-withdrawn rats. Pharmacol. Biochem. Behav. 68 4 (2001) 753-759
2. Andersen P.H. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. 3. Eur. J. Pharmacol. 166 3 (1989) 493-504
3. Archer T., Danysz W., Fredriksson A., Jonsson G., Luthman J., Sundstrom E., and Teiling A. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning. Pharmacol. Biochem. Behav. 31 2 (1988) 357-364
4. Barkley A.R. Attention Deficit Hyperactivity Disorder. second ed. (1998), The Guilford Press, New York, NY
5. Barnett R., Maruff P., and Vance A. An investigation of visuospatial memory impairment in children with attention deficit hyperactivity disorder (ADHD), combined type. Psychol. Med. 35 10 (2005) 1433-1443
6. Carli M., Evenden J.L., and Robbins T.W. Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature 313 6004 (1985) 679-688 21-27
7. Chuhan Y.S., and Taukulis H.K. Impairment of single-trial memory formation by oral methylphenidate in the rat. Neurobiol. Learn. Mem. 85 2 (2006) 125-131
8. Cilia J., Reavill C., Hagan J.J., and Jones D.N. Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats. Psychopharmacology 156 2-3 (2001) 327-337
9. Clemett D.A., Cockett M.I., Marsden C.A., and Fone K.C. Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function. J. Neurochem. 72 2 (1998) 883-884 Feb
10. Dix S.L., and Aggleton J.P. Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition. Behav. Brain Res. 99 2 (1999) 191-200
11. Ennaceur A., and Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav. Brain Res. 31 1 (1988) 47-59 1
12. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., and Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. 1. Biol. Psychiatry 57 11 (2005) 1313-1323
13. Feifel D., Minassian A., and Perry W. Prepulse inhibition of startle in adults with ADHD. J. Psychiatr. Res. 43 4 (2009) 484-489
14. van Gaalen M.M., Brueggeman R.J., Bronius P.F., Schoffelmeer A.N., and Vanderschuren L.J. Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology 187 1 (2006) 73-85
15. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 6566 (1996) 606-612 15
16. Giustino A., Beckett S., Ballard T., Cuomo V., and Marsden C.A. Perinatal cocaine reduces responsiveness to cocaine and causes alterations in exploratory behavior and visual discrimination in young-adult rats. Brain Res. 728 2 (1996) 149-156 29
17. Heikkila R.E., and Manzino L. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. Eur. J. Pharmacol. 103 3-4 (1984) 241-248 17
18. Hewitt K.N., Harwood B., Winney C., Penkethman S., Hollis C., Marsden C.A., and Fone K.C.F. Evaluation of a potential new animal model of attentional deficit hyperactivity disorder. J. Psychopharmacol. 15 (2001) A68
19. Hewitt K.N., Beal D.J., Hollis C., King M.V., Marsden C.A., and Fone K.C.F. GBR 12909 pre-treatment in rats alters attentional components of the 5-CSRTT during training and test sessions; a potential model for ADHD. J. Psychopharmacol. 18 3 (2004) A52
20. Hewitt K.N., Shah Y.B., Prior M.J., Morris P.G., Hollis C.P., Fone K.C.F., and Marsden C.A. Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder. Psychopharmacology 180 4 (2005) 716-723
21. van der Hoek G.A., and Cooper S.J. The selective dopamine uptake inhibitor GBR 12909: its effects on the microstructure of feeding in rats. Pharmacol. Biochem. Behav. 48 1 (1994) 135-140
22. Hooks M.S., Jones D.N., Holtzman S.G., Juncos J.L., Kalivas P.W., and Justice Jr. J.B. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole. Psychopharmacology 116 2 (1994) 217-225
23. Hotte M., Naudon L., and Jay T.M. Modulation of recognition and temporal order memory retrieval by dopamine D1 receptor in rats. Neurobiol. Learn. Mem. 84 2 (2005) 85-92
24. Johnson J.S., Hollingworth A., and Luck S.J. The role of attention in the maintenance of feature bindings in visual short-term memory. J. Exp. Psychol. Hum. Percept Perform. 34 1 (2008) 41-55
25. Keith V.A., Mansbach R.S., and Geyer M.A. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol. Psychiatry 30 6 (1991) 557-566 15
26. Kelley A.E., and Lang C.G. Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat. Eur. J. Pharmacol. 167 3 (1989) 385-395 29
27. King M.V., Sleight A.J., Woolley M.L., Topham I.A., Marsden C.A., and Fone K.C. 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation - an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47 2 (2004) 195-204
28. Krause J. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev. Neurother 8 4 (2008) 611-625 Review
29. Krause K.H., Dresel S.H., Krause J., la Fougere C., and Ackenheil M. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 27 7 (2003) 605-613
30. Madras B.K., Miller G.M., and Fischman A.J. The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). Behav. Brain Res. 130 1-2 (2002) 57-63
31. Mansbach R.S., Geyer M.A., and Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94 4 (1988) 507-514
32. Martinez Z.A., Ellison G.D., Geyer M.A., and Swerdlow N.R. Effects of sustained cocaine exposure on sensorimotor gating of startle in rats. Psychopharmacology 142 3 (1999) 253-260
33. Pardey M.C., Homewood J., Taylor A., and Cornish J.L. Re-evaluation of an animal model for ADHD using a free-operant choice task. J. Neurosci. Methods 176 2 (2009) 166-171 30
34. Rommelse N.N., Altink M.E., Arias-Vásquez A., Buschgens C.J., Fliers E., Faraone S.V., Buitelaar J.K., Sergeant J.A., Franke B., and Oosterlaan J. A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B 8 (2008) 1536-1546 5
35. Sagvolden T., Metzger M.A., Schiorbeck H.K., Rugland A.L., Spinnangr I., and Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav. Neural Biol. 58 2 (1992) 103-112
36. Sagvolden T., and Sergeant J.A. Attention deficit/hyperactivity disorder-from brain dysfunctions to behaviour. Behav. Brain Res. 94 1 (1998) 1-10
37. Sagvolden T., Russell V.A., Aase H., Johansen E.B., and Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol. Psychiatry 57 11 (2005) 1239-1247
38. Shilling P.D., Kelsoe J.R., and Segal D.S. Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats. Neurosci. Lett. 236 3 (1997) 131-134
39. Stepanov V., and Järv J. Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909). Neurochem. Int. 53 6-8 (2008) 370-373
40. Swanson J.M., Kinsbourne M., Nigg J., Lanphear B., Stefanatos G.A., Volkow N., Taylor E., Casey B.J., Castellanos F.X., and Wadhwa P.D. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol. Rev. 17 1 (2007) 39-59
41. Swerdlow N.R., Braff D.L., Geyer M.A., and Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiatry 21 1 (1986) 23-33
42. Swerdlow N.R., Braff D.L., Masten V.L., and Geyer M.A. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101 3 (1990) 414-420
43. Swerdlow N.R., Mansbach R.S., Geyer M.A., Pulvirenti L., Koob G.F., and Braff D.L. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 100 3 (1990) 413-416
44. Swerdlow N.R., Braff D.L., and Geyer M.A. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav. Pharmacol. 11 3-4 (2000) 185-204
45. Varty G.B., and Higgins G.A. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors?. Behav. Pharmacol. 9 5-6 (1998) 445-455
46. Viggiano D., Vallone D., and Sadile A. Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling. Neural Plast. 11 1-2 (2004) 97-114
47. Winsberg B.G., and Comings D.E. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J. Am. Acad. Child. Adolesc. Psychiatry 38 (1999) 1474-1477
48. Woolley M.L., Marsden C.A., Sleight A.J., and Fone K.C. Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790. Psychopharmacology 170 4 (2003) 358-367
49. Wultz B., Sagvolden T., Moser E.I., and Moser M.B. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav. Neural Biol. 53 1 (1990) 88-102
50. Xu X., Mill J., Sun B., Chen C.K., Huang Y.S., Wu Y.Y., and Asherson P. Association study of promoter polymorphisms at the dopamine transporter gene in attention deficit hyperactivity disorder. BMC Psychiatry 9 3 (2009) 5
51. van der Zee P., Koger H.S., Gootjes J., and Hespe W. Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15 (1980) 363